Comment on: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis”
American Journal of Cardiovascular Drugs · 2024
DOI: 10.1007/s40256-024-00644-6 ↗Kurz gefasst
Leserbrief in der Zeitschrift American Journal of Cardiovascular Drugs, 2024. Verfasst von Hussain Sohail Rangwala und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Jinnah Sindh Medical University, Iqbal Shaheed Rd, Karachi, Pakistan. srangwala01@gmail.com. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Aspirin, Renal Insufficiency, Chronic, Primary Prevention. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Jinnah Sindh Medical University, Iqbal Shaheed Rd, Karachi, Pakistan. srangwala01@gmail.com.
- Department of Medicine, Jinnah Sindh Medical University, Iqbal Shaheed Rd, Karachi, Pakistan.
Zitieren
APA
Rangwala, H. S., Fatima, H., & Rangwala, B. S. (2024). Comment on: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis”. American Journal of Cardiovascular Drugs. https://doi.org/10.1007/s40256-024-00644-6
Vancouver
Rangwala HS, Fatima H, Rangwala BS. Comment on: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis”. American Journal of Cardiovascular Drugs. 2024. doi:10.1007/s40256-024-00644-6
BibTeX
@article{Rangwala2024,
author = {Rangwala, Hussain Sohail and Fatima, Hareer and Rangwala, Burhanuddin Sohail},
title = {Comment on: “Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis”},
journal = {American Journal of Cardiovascular Drugs},
year = {2024},
doi = {10.1007/s40256-024-00644-6}
}
EUVIMED